The next board meeting for Rigel Pharmaceuticals is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment ConferenceSee details
Rigel Pharmaceuticals has a share price target of US$ 38, revenue growth forecast of 56.8%, and profit growth estimate of 393.9% for FY25, based on top 6 analyst calls.